Lower extremity function in normal cognitive aging, mild cognitive impairment, and Alzheimer’s disease

L.H.P. Eggermont, B.E. Gavett, K.M. Volkers, C.G. Blankevoort, E.J.A. Scherder, A.L. Jefferson, E. Steinberg, A. Nair, R.C. Green, R.A. Stern

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Eggermont LH, Gavett BE, Volkers KM, Blankevoort CG, Scherder EJ, Jefferson AL, Steinberg E, Nair A, Green RC, Stern RA. Lower-extremity function in cognitively healthy aging, mild cognitive impairment, and Alzheimer's disease. Objective: To examine differences in lower-extremity function in cognitive healthy older persons, older persons with mild cognitive impairment (MCI), and older persons with Alzheimer's disease (AD). Design: Descriptive study. Setting: University Alzheimer's disease clinical and research program. Participants: Older persons (N=66) were studied (mean age, 76.7y); 22 were cognitively normal, 22 were diagnosed with probable MCI, 22 were diagnosed with probable AD. Interventions: Not applicable. Main Outcome Measures: Lower-extremity function was assessed by the four-meter walk test (4MWT), Timed Up & Go (TUG) test, and sit-to-stand (STS) test. Results: Analysis of variance, adjusting for covariates, revealed that performance on the 4MWT was significantly lower in the MCI and AD groups as compared with controls. TUG test performance was worse in the AD group compared with controls. No significant group differences were found for STS performance. Conclusions: These results suggest an association between cognitive impairment and lower-limb function in older persons. Walking speed could be evaluated for its possible utility in screening older persons at risk for cognitive impairment and falls. © 2010 American Congress of Rehabilitation Medicine.
Original languageEnglish
Pages (from-to)584-588
Number of pages5
JournalArchives of Physical Medicine and Rehabilitation
Volume91
DOIs
Publication statusPublished - 2010

Fingerprint Dive into the research topics of 'Lower extremity function in normal cognitive aging, mild cognitive impairment, and Alzheimer’s disease'. Together they form a unique fingerprint.

  • Cite this